Weifei Lu
Impact in
- Inorganic Chemistry top 10%
- Metal-Organic Frameworks: Synthesis and Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoplatforms for cancer theranostics 3
- Graphene and Nanomaterials Applications 2
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Hao Hong (8 shared papers)Dongzhi Yang (5 shared papers)Ting Cai (2 shared papers)Marcian E. Van Dort (3 shared papers)Brian D. Ross (3 shared papers)Daiqin Chen (3 shared papers)Hongwei Wu (1 shared paper)Xianran He (1 shared paper)
- Journals
- Acta Biomaterialia (2 papers)ACS Applied Materials & Interfaces (2 papers)Molecular Pharmaceutics (1 paper)Biotechnology Letters (1 paper)Oncotarget (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weifei Lu
13 papers receiving 432 citations
Peers
Comparison fields: 5 of 76
- Inorganic Chemistry 166
- Biomaterials 119
- Biomedical Engineering 228
- Materials Chemistry 166
- Polymers and Plastics 41
Countries citing papers authored by Weifei Lu
This map shows the geographic impact of Weifei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weifei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weifei Lu more than expected).
Fields of papers citing papers by Weifei Lu
This network shows the impact of papers produced by Weifei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weifei Lu. The network helps show where Weifei Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weifei Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 261 | |
| 2 | 2018 | 38 | |
| 3 | 2018 | 24 | |
| 4 | 2019 | 23 | |
| 5 | 2017 | 19 | |
| 6 | 2020 | 14 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 9 | |
| 10 | 2017 | 8 | |
| 11 | 2018 | 6 | |
| 12 | 2016 | 6 | |
| 13 | 2021 | 4 |
About Weifei Lu
Weifei Lu is a scholar working on Biomedical Engineering, Cancer Research, Organic Chemistry, Molecular Biology and Epidemiology, having authored 13 papers that have together received 437 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (3 papers), Boron Compounds in Chemistry (2 papers), Fullerene Chemistry and Applications (2 papers), Graphene and Nanomaterials Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Graphene research and applications (2 papers), Autophagy in Disease and Therapy (2 papers) and Advanced biosensing and bioanalysis techniques (1 paper). The work is most often cited by research in Inorganic Chemistry (166 citations), Biomaterials (119 citations), Biomedical Engineering (228 citations), Materials Chemistry (166 citations) and Polymers and Plastics (41 citations). Weifei Lu has collaborated with scholars based in China and United States. Frequent co-authors include Hao Hong, Dongzhi Yang, Ting Cai, Marcian E. Van Dort, Brian D. Ross, Daiqin Chen, Hongwei Wu, Xianran He, Casey A. Dougherty and Yihua Yin. Their work appears in journals such as Acta Biomaterialia, ACS Applied Materials & Interfaces, Molecular Pharmaceutics, Biotechnology Letters and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.